Vitrolife — Board/Management Information 2021

Sep 2, 2021

Press Release September 2, 2021 Gothenburg, Sweden

Vitrolife´s CFO leaves

Vitrolife's Chief Financial Officer (CFO) Mikael Engblom has today resigned from his position. A process to recruit a replacement will be initiated and Mikael Engblom will continue in his current role until a new CFO takes office. Mikael Engblom has been CFO since 2011 and before that worked as a controller at the company.

"During his time as CFO, Mikael has played a key role in transforming the company from a small niche company to a very profitable market-leading player in reproductive health with an international ownership base through internal efficiency work, strategy plans and acquisitions," says Thomas Axelsson, CEO. "I would like to thank Mikael for good cooperation and his valuable contribution to the company's exceptional development over the past ten years and wish him best of luck for the future," says Thomas Axelsson, CEO.

"Vitrolife is facing a new exciting growth journey, but after ten developing years as CFO at Vitrolife, I have decided that it is time for a new challenge," says Mikael Engblom.

Gothenburg, September 2, 2021 VITROLIFE AB (publ) Thomas Axelsson, CEO

Contact persons:

Thomas Axelsson, CEO, tel: +46 31 721 80 01 Mikael Engblom, CFO, tel: +46 31 721 80 14

___________________________________________________________________________________________________________________________________

.

_____________________________________________________________________________________________________

The information was submitted for publication, through the agency of the contact persons set out above, at 3 pm CET on September 2, 2021.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Vitrolife AB (publ), Box 9080, SE-400 92 Gothenburg. Corporate ID number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com